Edition:
United States

IntelliPharmaCeutics International Inc (IPCI.OQ)

IPCI.OQ on NASDAQ Stock Exchange Capital Market

2.80USD
6 Dec 2016
Change (% chg)

-- (--)
Prev Close
$2.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
55,294
52-wk High
$3.34
52-wk Low
$1.41

IPCI.OQ

Chart for IPCI.OQ

About

IntelliPharmaCeutics International Inc is a Canada-based pharmaceutical company specializing in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the developmen... (more)

Overall

Beta: 0.98
Market Cap(Mil.): $81.66
Shares Outstanding(Mil.): 29.36
Dividend: --
Yield (%): --

Financials

  IPCI.OQ Industry Sector
P/E (TTM): -- 29.64 30.37
EPS (TTM): -0.37 -- --
ROI: -438.94 15.79 15.17
ROE: -457.30 16.91 16.51

BRIEF-Intellipharmaceutics submits new drug application for Rexista

* Intellipharmaceutics submits new drug application for Rexista (oxycodone hydrochloride extended release), an abuse deterrent opioid analgesic for the treatment of moderate to severe pain

Nov 25 2016

BRIEF-Intellipharmaceutics announces third quarter 2016 results

* Q3 earnings per share view $-0.07 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Oct 14 2016

BRIEF-Intellipharmaceutics signs an exclusive license deal with Mallinckrodt

* Intellipharmaceutics signs an exclusive license and commercial supply agreement with mallinckrodt

Oct 11 2016

BRIEF-Intellipharmaceutics announces FDA tentative approval for generic Seroquel XR

* Says received tentative approval from u.s. Fda for co's new drug application for quetiapine fumarate

Oct 07 2016

BRIEF-Intellipharmaceutics responds to recent trading activity

Sept 22 Intellipharmaceutics International Inc :

Sep 22 2016

BRIEF-Intellipharmaceutics reports Q2 loss per share $0.08

* Q2 loss per share $0.08 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

Jul 13 2016

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $60.28 +0.03
Novartis AG (NOVN.S) CHF69.65 +0.25
Johnson & Johnson (JNJ.N) $112.06 +0.12
Pfizer Inc. (PFE.N) $31.56 -0.03

Earnings vs. Estimates